Screener / SEC EDGAR /CIK 0000049071 /10-K filed Feb 19, 2026, compared with Feb 20, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Health Insurance

Humana HUM

Compare with peers Embed
SEC comment letters, last 20 years

2 reviews of HUM's filings by SEC staff

UPLOAD and CORRESP
Reviews 2 latest letter Sep 20, 2022
Questions asked 4 each answered in the company's own letter
No closing letter 0 reviews without a letter saying the staff completed it

When the SEC's staff reviews a filing, it writes to the company with numbered questions, and the company answers each one in a letter. SEC publishes the exchange once the review is over, at least 20 business days later. A question is not an accusation; most reviews end with the company adding detail to its next filing.

How the reviews went

Every review on EDGAR, from the first staff letter to the letter that closes it

  1. 1. Staff letters 2 UPLOAD
  2. 2. Questions in them 4 numbered comments
  3. 3. Company replies 1 CORRESP
  4. 4. Reviews closed 2 of 2 closing letter

Half the closed reviews took 41 days or less from the first letter to the closing letter.

Schedule 14A

2022-09-20 to 2022-10-06 · 3 questions · 1 letter from the SEC, 0 from the company
Review closed 2022-10-06
Controls
SEC letter of Sep 20, 2022 ↗ no reply letter on EDGAR (the company may have answered in an amended filing)
Definitive Proxy Statement on Schedule 14A filed March 9, 2022 · General
SEC asked (1)
Please expand your discussion of the reasons you believe that your leadership structure is appropriate, addressing your specific characteristics or circumstances. In your discussion, please also address the circumstances under which you would consider having the Chair and CEO roles filled by a single individual, when shareholders would be notified of any such change, and whether you will seek prior input from
Rest of the question

shareholders.

HUM answered

No reply letter found.

Definitive Proxy Statement on Schedule 14A filed March 9, 2022 · General
SEC asked (2)
Please expand upon the role that your Chair plays in the leadership of the board. For example, please enhance your disclosure to address whether or not your Chair may: • require board consideration of, and/or override your CEO on, any risk matters; or • provide input on design of the board itself.
HUM answered

No reply letter found.

Definitive Proxy Statement on Schedule 14A filed March 9, 2022 · General
SEC asked (3)
Please expand upon how your board administers its risk oversight function. For example, please disclose: • the timeframe over which you evaluate risks (e.g., short-term, intermediate-term, or long-term) and how you apply different oversight standards based upon the immediacy of the risk assessed; • whether you consult with outside advisors and experts to anticipate future threats and trends, and how often you
Rest of the question

re-assess your risk environment; • how the board interacts with management to address existing risks and identify significant emerging risks; • to whom your Chief Compliance Officer reports; and • how your risk oversight process aligns with your disclosure controls and procedures.

HUM answered

No reply letter found.

Also in this review: closing letter, 2022-10-06

Form 10-K for the Fiscal Year Ended December 31, 2017

2018-05-08 to 2018-06-18 · 1 question · 1 letter from the SEC, 1 from the company
Review closed 2018-06-18
Goodwill and impairmentReserves and insurance
Note 2: Summary of Significant Accounting Policies · Sale of Closed Block of Commercial Long-Term Care Insurance Business, page 86
SEC asked
You disclose here that you expect a loss of approximately $365 million upon the sale of KMG America Corporation expected to close in the third quarter of 2018 and update this expected loss to approximately $350 million on page 8 of your March 31, 2018 Form 10- Q.
Rest of the question

Please tell us why you do not record any of this anticipated loss at December 31, 2017 or March 31, 2018 and reference for us the authoritative literature you relied upon to support your accounting. In your response specifically tell us whether your impending sale of KMG America Corporation qualifies for held for sale classification as stipulated in ASC 360-10-45-9 and address the following: • If so, tell us: o Why you do not record the apparent $365 million in loss in fair value at December 31, 2017 and the apparent $15 million recovery at March 31, 2018 as stipulated in ASC 360-10-35-38 through 35-42; o How your ongoing accounting complies with ASC 360-10-35-43; o How your presentation complies with ASC 360-10-45-14; and o How your disclosure complies with ASC 360-10-50-3A; • If not, tell us why you fail to qualify for held for sale classification and separately explain whether there is any asset impairment associated with this subsidiary and your assessment for additional loss reserves associated with the long-term care policies or any other policies at this subsidiary; and • In any regard, provide us the computations of your expected losses at both December 31, 2017 and March 31, 2018.

HUM answered

No numbered answer found in the reply. Read the reply ↗

In its next report

First report after the company's reply of May 21, 2018: 10-Q filed Aug 1, 2018 ↗, against the 10-Q filed May 2, 2018 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: closing letter, 2018-06-18

Letters without questions

Other letters

UPLOAD and CORRESP
1 other letter: notices that a filing will not be reviewed, requests to declare a registration effective, and the like
  • Sep 29, 2022 · HUM: letter · Humana Inc. · Definitive Proxy Statement on Schedule 14A · Filed March 9, 2022 · File...

From the SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), 6 letters filed since 2018-05-08. Questions and answers are matched by their numbers; topics come from words in each question. The reports are compared word for word (same form, before the first SEC letter against the first report after the company's reply). No AI.

Sources

The SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), matched question by question. No AI.

Also

Filings: the letters in the filing list.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/HUM/export.csv") into a cell.

Next in Owners and insiders:Insider trades
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.